Cardica, Inc.  

(Public, NASDAQ:CRDC)   Watch this stock  
Find more results for CRDC
1.14
+0.04 (3.64%)
Jul 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.12 - 1.15
52 week 0.82 - 1.61
Open 1.13
Vol / Avg. 0.00/218,364.00
Mkt cap 101.38M
P/E     -
Div/yield     -
EPS -0.31
Shares 88.93M
Beta 1.52
Inst. own 38%
Aug 4, 2014
Q4 2014 Cardica, Inc. Earnings Release (Estimated) Add to calendar
May 1, 2014
Q3 2014 Cardica, Inc. Earnings Conference Call - Webcast
May 1, 2014
Q3 2014 Cardica, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -468.84% -461.19%
Operating margin -455.46% -447.56%
EBITD margin - -414.58%
Return on average assets -188.71% -89.89%
Return on average equity -904.90% -144.51%
Employees 66 -
CDP Score - -

Address

900 Saginaw Drive
REDWOOD CITY, CA 94063
United States - Map
+1-650-3649975 (Phone)
+1-650-3643134 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cardica, Inc. (Cardica) is focused on the development of an endoscopic microcutter product line intended for use by thoracic, bariatric, colorectal and general surgeons. The first product that it is developing in its microcutter product line is the Microcutter XPRESS 30, the multi-fire endolinear microcutter device based on its staple-on-a-strip technology. In addition, the Company is developing the Microcutter XPRESS 45, a multi-fire endolinear microcutter device with a 45 millimeter staple line, the Microcutter XCHANGE 30, a cartridge based microcutter device with a 5 millimeter shaft diameter and a 30 millimeter staple line, the Microcutter FLEXCHANGE 30, a cartridge based microcutter device with a flexible shaft to facilitate endoscopic procedures requiring cutting and stapling, and the Microcutter XPRESS 60, a cutting and stapling device specifically designed for the bariatric and thoracic surgery markets.

Officers and directors

Kevin T. Larkin Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Bernard A. Hausen M.D.,Ph.D. President, Chief Executive Officer, Chief Medical Officer, Director
Age: 53
Bio & Compensation  - Reuters
Robert Y. Newell IV Chief Financial Officer, Vice President - Finance
Age: 65
Bio & Compensation  - Reuters
Frederick M. Bauer Vice President - Operations
Age: 59
Bio & Compensation  - Reuters
Liam Burns Vice President - Sales and Marketing
Bio & Compensation  - Reuters
Bryan D. Knodel Ph.D. Vice President - Research & Development
Age: 53
Bio & Compensation  - Reuters
Richard P. Powers Independent Director
Age: 69
Bio & Compensation  - Reuters
Jeffrey L. Purvin Independent Director
Age: 61
Bio & Compensation  - Reuters
John G. Simon PhD Independent Director
Age: 41
Bio & Compensation  - Reuters
William H. Younger Jr. Independent Director
Age: 64
Bio & Compensation  - Reuters